Detalhe da pesquisa
1.
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies.
Blood
; 140(1): 38-44, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35421218
2.
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Mol Ther
; 30(2): 550-563, 2022 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478871
3.
TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia.
Haematologica
; 108(8): 2229-2233, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36655434
4.
Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis.
Haematologica
; 104(2): e54-e58, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30237260
5.
Factor-inhibiting HIF (FIH) promotes lung cancer progression.
JCI Insight
; 8(20)2023 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707961
6.
Enabling CAR-T cells for solid tumors: Rage against the suppressive tumor microenvironment.
Int Rev Cell Mol Biol
; 370: 123-147, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798503
7.
A flow cytometry-based neutralization assay for simultaneous evaluation of blocking antibodies against SARS-CoV-2 variants.
Front Immunol
; 13: 1014309, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36505411
8.
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.
Cancer Immunol Res
; 10(4): 498-511, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362043
9.
CCR4 expression in a case of cutaneous Richter's transformation of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) and in CLL patients with no skin manifestations.
Eur J Haematol
; 87(1): 80-6, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21443542
10.
Enforced sialyl-Lewis-X (sLeX) display in E-selectin ligands by exofucosylation is dispensable for CD19-CAR T-cell activity and bone marrow homing.
Clin Transl Med
; 11(2): e280, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33634970
11.
Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.
J Immunother Cancer
; 8(2)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32868394
12.
Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope.
J Immunother Cancer
; 8(2)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32788237
13.
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo.
J Immunother Cancer
; 8(1)2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527933
14.
CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity.
Leukemia
; 33(8): 2090-2125, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778134